Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2018-10-30 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2018年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2018 年第三季度报告" which translates to "2018 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2018. The report includes unaudited financial statements and comprehensive financial metrics for the period ending September 30, 2018. The presence of quarterly financial data and the term "季度报告" (quarterly report) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2018
2018-10-30 Chinese
第三届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the first meeting of the third board of directors of Zhengzhou Antu Biological Engineering Co., Ltd. It details the election of board chairman, vice chairman, committee members, appointment of senior management, and approval of the 2018 third quarter report. The document repeatedly references that detailed content is disclosed on the Shanghai Stock Exchange website and includes voting results. The document length is short (1628 characters) and primarily serves as an announcement of board and management changes and meeting resolutions rather than the full report itself. Therefore, it fits best under 'Board/Management Information' (MANG) as it announces changes in the company's board and senior management and related resolutions.
2018-10-30 Chinese
独立董事关于公司第三届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhengzhou Antu Bioengineering Co., Ltd. regarding matters discussed at the first meeting of the third board of directors. It references compliance with company law, stock exchange listing rules, and company articles, and covers topics such as election of board chairman, vice chairman, committee members, appointment of senior management, and approval of senior management remuneration. The document is a formal opinion on board/management matters rather than a full report or announcement of voting results. It does not contain financial statements or detailed financial data. The content aligns with announcements related to board or management information, specifically changes or confirmations in board and senior management positions and related approvals. The document length is short (881 characters), and it is not a report publication announcement or certification letter. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-10-30 Chinese
关于选举公司副董事长的公告
Board/Management Information Classification · 100% confidence The document is an announcement from the board of Zhengzhou Antu Biological Engineering Co., Ltd. regarding the election of a new vice chairman of the board. It includes details about the election process, qualifications of the elected individual, and a brief biography. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder votes or dividends. The content clearly relates to changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification.
2018-10-30 Chinese
2018年第一次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of the 2018 first extraordinary general meeting (临时股东大会) of Zhengzhou Antu Bioengineering Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document focuses on the legal validation of the meeting process and the election of directors and supervisors. It is not a financial report, earnings release, or management discussion. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's legality. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal document related to corporate governance and shareholder meetings but does not fit the more specific categories like AGM Information or Declaration of Voting Results. The document length (5064 characters) and content confirm it is a standalone legal opinion letter, not a report publication announcement or a full report.
2018-10-29 Chinese
2018年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2018 first extraordinary shareholders' meeting of Zhengzhou Antu Biological Engineering Co., Ltd. It details the meeting date, attendance, voting results on director and supervisor elections, and legal witness statements confirming the legality of the meeting and resolutions. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and supervisory appointments and voting outcomes. This matches the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 3,000 characters, consistent with a detailed voting result announcement rather than a full report or presentation.
2018-10-29 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.